Last reviewed · How we verify
fenthion
Fenthion is a small molecule compound originally developed by the French company Rhône-Poulenc. It is used as an organophosphate insecticide and acaricide. The commercial status of fenthion is not well-documented, but it is likely to be off-patent. Fenthion works by inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine, leading to overstimulation of muscles and nerves. Key safety considerations include its potential to cause cholinergic toxicity and environmental contamination.
At a glance
| Generic name | fenthion |
|---|---|
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fenthion CI brief — competitive landscape report
- fenthion updates RSS · CI watch RSS
- portfolio CI